Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
05/2008
05/15/2008DE102006053380A1 Chlorinated or partly chlorinated carbonyl compound production for use in pharma and agro industry, involves introducing unchlorinated or partly chlorinated carbonyl compound in jet loop reactor
05/15/2008CA2672956A1 Calcium receptor modulating agents
05/14/2008EP1919885A1 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives
05/14/2008EP1919858A2 Management of ophthalmologic disorders, including macular degeneration
05/14/2008EP1692105B1 Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives
05/14/2008EP1575922B1 Biphenyl derivatives and their use as fungicides
05/14/2008CN201058855Y Highly effective gas-carrying acrylamide water solution concentrating tower
05/14/2008CN101180267A Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof
05/14/2008CN101180266A Alpha ketoamide compounds as cysteine protease inhibitors
05/14/2008CN101177403A Method for preparing N-dimethylamino propyl methyl acrylamide
05/14/2008CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease
05/14/2008CN100387581C Process to produce oxazolidinones
05/13/2008US7371890 Functional groups are each independently selected from nitrile group, carboxylic acid group, carboxylic ester group and carboxamide group; the compound that contains the two functional groups is obtained by monoaddition of two terminal olefins and hydrogenation
05/13/2008US7371888 α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
05/13/2008US7371877 Glycerol ester derivative
05/13/2008US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action
05/13/2008CA2214894C Substituted dibenz[a,f]azulenes and methods of preparation
05/08/2008WO2008054154A1 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
05/08/2008WO2008053393A2 Rotary actuator
05/08/2008WO2008035380A3 An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
05/08/2008US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide
05/08/2008CA2667855A1 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same
05/07/2008EP1918272A1 Pharmaceutically active compounds and methods of use
05/07/2008EP1917253A1 Method for producing betamimetics
05/07/2008EP1917241A2 Bicyclic derivatives as p38 kinase inhibitors
05/07/2008EP1694630B1 Method for producing chiral or enantiomer-enriched beta-amino acids, -aldehydes, -ketones and gamma-amino alcohols
05/07/2008EP1644318B1 Method for synthesizing ceramide-type compounds
05/07/2008CN101175777A (methyl)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and method for forming pattern
05/07/2008CN101172957A Selective inhibitors of viral or bacterial neuraminidase
05/06/2008US7368415 Substituted beta-(oxazolidin-3-ylcarbonyl)styrenes: 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for delivering fragrances to a laundary detergent, shampoo or hair conditioner
05/06/2008US7368101 Process for the preparation of iopamidol and the new intermediates therein
05/06/2008CA2239694C Indane dimer compounds and their pharmaceutical use
05/02/2008WO2008049808A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
05/02/2008WO2008049729A1 Non-steroidal brassinosteroid mimetic
05/02/2008WO2008002676A3 Biaryl compositions and methods for modulating a kinase cascade
05/02/2008CA2666539A1 Substituted phenylmethyl bicyclocarboxyamide compounds
05/02/2008CA2666124A1 Non-steroidal brassinosteroid mimetic
05/02/2008CA2664794A1 Substituted imidazoles as bombesin receptor subtype-3 modulators
05/02/2008CA2664143A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
05/01/2008US20080103328 Synthetic and semisynthetic acanthoic acid derivatives; antiinflammatory, anticancer and antitumor agents
05/01/2008US20080103311 Retroviral protease inhibitors
04/2008
04/30/2008EP1915337A1 Hydroxybenzamide derivatives, the method for preparing thereof and the cosmetic composition containing the same
04/30/2008EP1915336A1 Process for producing high-purity n-vinylcarboxamides
04/30/2008EP1915335A2 Process for the preparation of cinacalcet base
04/30/2008EP1506168B1 Gelling agents
04/30/2008CN101171229A Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
04/30/2008CN101168517A Method for preparing capsaicin microcapsule
04/30/2008CN100384824C Acetyl 2-hydroxy-1, 3-diaminoalkanes
04/30/2008CN100384814C Methods for preparing nateglinide crystals
04/30/2008CN100384813C Process for preparing nateglinide and intermediates thereof
04/30/2008CN100384349C Method for using bamboo leaf extract as acrylamide suppressor for heat processing food
04/29/2008US7365203 Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile
04/29/2008US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX
04/29/2008US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
04/29/2008CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives
04/29/2008CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders
04/24/2008WO2008047547A1 Novel compound, composition comprising the same, and process for production of polymerizable amide
04/24/2008WO2008046895A1 Substituted bicyclo[4.1.0]heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances
04/24/2008US20080097127 Diisopropyl-(3-phenyl-3-p-tolyloxy-propyl)-amine; medicament useful in the treatment of urinary incontinence
04/24/2008US20080097100 Opiate Intermediates and Methods of Synthesis
04/24/2008US20080096970 Stable Nateglinide Form B Compositions
04/24/2008US20080096969 L-N alpha -(menthanecarboxyl)glycine-N-isobutylamide; mixture additionally cause a flavor-modulating effect and/or a trigeminal and/or a salivatory stimulus; on the skin and/or mucous membranes; for nutrition, pleasure, oral hygiene, a pharmaceutical, or a cosmetic; nonhydrolyzing
04/24/2008US20080096942 Beta-secretase inhibitors; use in treating Alzheimer's disease; for example, N-{(1S,2R)-1-[3-(cyclohexylmethyl)benzyl]-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}acetamide hydrochloride
04/24/2008US20080096920 3-{4-[Bis-(quinolin-8-ylcarbamoylmethyl)-amino]-phenyl}-N-hydroxy-acrylamide; 4-(2-Hydroxycarbamoyl-vinyl)-N,N-bis-phenylcarbamoylmethyl-benzamide; useful in treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, and neurdegenerative disorders
04/24/2008US20080096917 for plants; 2-(dibenzofuranyl-2-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(indanyl-5-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; 2-(3-phenylquinolinyl-6-oxy)-2-methylthio-N-(2-methylpent-3-yn-2-yl)acetamide; phytopathogenic fungi
04/24/2008US20080096892 C-Kit Modulators And Methods Of Use
04/24/2008US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
04/24/2008US20080096848 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis
04/24/2008US20080095704 A polyoxyethylene glycol having a molecular weight of < 3000 Da and 2-50 ethylene glycol units, an imageable moiety anda non-peptidic vector moiety provided that the vector does not have affinity for the Angiotensin II receptor; enhanced contrast; tomography (SPECT); PET sccans; MRIs
04/24/2008CA2664612A1 Novel compound, composition comprising the same, and process for production of polymerizable amide
04/23/2008EP1914223A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
04/23/2008EP1912932A2 Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators
04/23/2008EP1167345B1 Method of purifying amide compound
04/23/2008CN101166722A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
04/23/2008CN100382888C Process for preparing acrylonitrile hydrated copper base catalyst by coprecipitation method
04/22/2008USRE40259 side effects reduction; compounds active on the central nervous system; chronic and neuropathic pain, anti-epileptic, anti-Parkinson, neuroprotective, antidepressant, antispastic and hypnotic agents; 2-[4-(3-fluorobenzyloxy)benzylamino]-2-methylpropanamide
04/22/2008US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
04/22/2008US7361786 Polymer enlarged ligands or complexes advantageous in catalytic processes carried out in a membrane reactor; high enantiomeric purity
04/22/2008US7361785 lower toxicity to the body, a higher degree of safety, and an equal or better UV ray protection effect; naphthyl or benzyl carboxylate derivatives
04/22/2008US7361688 Substituted aminoalcohols useful in treatment of Alzheimer's disease
04/22/2008US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis
04/22/2008US7361376 such as 2,6-nonadienamide,N-2-propenyl-,(2E,6Z); organoleptic; for addition to foods, beverages, medicine, and toothpaste
04/17/2008WO2008043495A1 Method for producing alkaline fatty acid amides
04/17/2008WO2008043494A1 Method for producing tertiary amides of alkylphenyl carboxylic acids
04/17/2008WO2008043493A1 Method for producing fatty acid alkanol amides
04/17/2008WO2008043492A1 Method for producing alkaline (meth)acrylamides
04/17/2008WO2007139933A3 Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
04/17/2008US20080090916 2-Amino-4-[(1S,2R)-2-(2,5-dimethoxyphenyl)-2-hydroxy-1-methyl-ethylcarbamoyl]butyric acid, aka gamma-L-glutamyl-1R,2S-methoxamine; prodrug of 1R,2S-methoxamine that is converted within the kidney tubules into its active form; transdermal administration; coupling methoxamine with glutamic acid alcohol
04/17/2008US20080090913 Sphingolipid-Derived Phamaceutical Compositions
04/17/2008US20080090803 Fatty alcohol drug conjugates
04/17/2008US20080090796 Useful in the treatment of neurological and psychiatric disorders associated with glutamatergic neurotransmission dysfunction and diseases; schizophrenia; 2,4-dichloro-N-{[4-(cyclopropylmethyl)-1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl]methyl}benzamide
04/17/2008US20080087861 Wrinkle-Removing Composition
04/17/2008DE19711925B9 Verfahren zur Reinigung von N-Vinylformamid A process for purifying N-vinylformamide
04/17/2008CA2666173A1 Method for producing tertiary amides of alkylphenyl carboxylic acids
04/17/2008CA2666171A1 Method for producing basic (meth)acrylamides
04/16/2008EP1911740A1 Potassium channel modulators
04/16/2008EP1426356B1 Intermediate compounds for the preparation of mirtazapine and the production methods thereof
04/16/2008EP1414787B1 New derivatives of substituted anilines with herbicidal activity
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/16/2008CN101161636A Method for purifying capsicine
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 289